Cargando…

In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma

Cytostatic effects of doxorubicin in clinically applied doses are often inadequate and limited by systemic toxicity. The main objective of this in vitro study was to determine the anti-tumoral effect (IC(50)) and intracellular accumulation of free and liposomal doxorubicin (DOX) in four human cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kullenberg, Fredrik, Degerstedt, Oliver, Calitz, Carlemi, Pavlović, Nataša, Balgoma, David, Gråsjö, Johan, Sjögren, Erik, Hedeland, Mikael, Heindryckx, Femke, Lennernäs, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306283/ https://www.ncbi.nlm.nih.gov/pubmed/34359887 http://dx.doi.org/10.3390/cells10071717

Ejemplares similares

Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
por: Balgoma, David, et al.
Publicado: (2021)

Orthogonality in Principal Component Analysis Allows the Discovery of Lipids in the Jejunum That Are Independent of Ad Libitum Feeding
por: Balgoma, David, et al.
Publicado: (2022)

Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma
por: Calitz, Carlemi, et al.
Publicado: (2023)

Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile
por: Dubbelboer, Ilse R., et al.
Publicado: (2019)

Inhibiting IRE1α-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma
por: Pavlović, Nataša, et al.
Publicado: (2020)

The progression of doxorubicin-induced intestinal mucositis in rats
por: Kullenberg, F., et al.
Publicado: (2022)

Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
por: Nyman, Sofi Sennefelt, et al.
Publicado: (2022)

Exploring the Role of Endoplasmic Reticulum Stress in Hepatocellular Carcinoma through mining of the Human Protein Atlas
por: Pavlović, Nataša, et al.
Publicado: (2021)

Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma
por: Ebeling Barbier, Charlotte, et al.
Publicado: (2021)

Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
por: Khaled, Jaafar, et al.
Publicado: (2022)

Platelets as Key Factors in Hepatocellular Carcinoma
por: Pavlovic, Natasa, et al.
Publicado: (2019)

Inhibiting P2Y12 in Macrophages Induces Endoplasmic Reticulum Stress and Promotes an Anti-Tumoral Phenotype
por: Pavlović, Nataša, et al.
Publicado: (2020)

The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin
por: Dahlgren, David, et al.
Publicado: (2020)

Anabolic androgenic steroids exert a selective remodeling of the plasma lipidome that mirrors the decrease of the de novo lipogenesis in the liver
por: Balgoma, David, et al.
Publicado: (2020)

Comprehensive Peak Characterization (CPC) in Untargeted LC–MS Analysis
por: Pirttilä, Kristian, et al.
Publicado: (2022)

Oogenesis and lipid metabolism in the deep-sea sponge Phakellia ventilabrum (Linnaeus, 1767)
por: Koutsouveli, Vasiliki, et al.
Publicado: (2022)

Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats
por: Dahlgren, David, et al.
Publicado: (2021)

Anticancer Potential of Sutherlandia frutescens and Xysmalobium undulatum in LS180 Colorectal Cancer Mini-Tumors
por: Gouws, Chrisna, et al.
Publicado: (2021)

Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat
por: Dahlgren, David, et al.
Publicado: (2020)

Herb-Drug Pharmacokinetic Interactions: Transport and Metabolism of Indinavir in the Presence of Selected Herbal Products
por: Calitz, Carlemi, et al.
Publicado: (2015)

Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats
por: Cano-Cebrián, Maria-José, et al.
Publicado: (2022)

Evaluation and validation of chemotherapy‐specific diarrhoea and histopathology in rats
por: Dahlgren, David, et al.
Publicado: (2022)

Rifampicin–Liposomes for Mycobacterium abscessus Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation
por: Rinaldi, Federica, et al.
Publicado: (2021)

Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake in vivo
por: Bellary, Aditi, et al.
Publicado: (2020)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Enhancement of Both Intracellular Uptake and Antitumor Action of Cisplatinum on Human Neuroblastoma Cells by Encapsulation in Liposomes
por: Kamio, Yoshiro, et al.
Publicado: (1989)

Intracellular Distribution of Lipids and Encapsulated Model Drugs from Cationic Liposomes with Different Uptake Pathways
por: Takikawa, Masato, et al.
Publicado: (2020)

PEG(2000)-DBCO surface coating increases intracellular uptake of liposomes by breast cancer xenografts
por: Liu, Daxing, et al.
Publicado: (2022)

Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, Doxorubicin
por: Swietach, Pawel, et al.
Publicado: (2012)

Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin
por: Chen, Wei-liang, et al.
Publicado: (2017)

Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models
por: Dahlgren, David, et al.
Publicado: (2020)

Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
por: Islam, Md. Rakibul, et al.
Publicado: (2022)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Liposomal doxorubicin-induced palmoplantar erythrodysthesia syndrome
por: Yadav, Nidhi, et al.
Publicado: (2015)

Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes
por: Mehn, Dora, et al.
Publicado: (2017)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
por: Liu, Zongyu, et al.
Publicado: (2017)

Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
por: Aloss, Kenan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ddusq85bl7jfd6e784odr153nl